Japanese team creates COVID treatment with synthetic immune cells
This content was published in August 16, 2024 – 08:56 Tokyo, Aug 16 (EFE).- A Japanese research team made up of scientists from Kyoto University and Fujita Health University has developed a new drug against COVID-19 based on immune cells synthesized from stem cells. The team plans to conduct a clinical trial within three years … Read more